Lnx Research White Paper
Finding Key Opinion Leaders With Large Scale SNA
-
Lnx Pharma White Paper #2 | Finding Key Opinion Leaders Using Large Scale Social Network Analysis
Date published: 2009
A COMPARATIVE ANALYSIS OF METHODS FOR FINDING KEY OPINION LEADERS
Key Takeaway: This whitepaper compares and contrasts the four traditional methods of KOL identification and we introduce a new method to more empirically identify KOLs. Perhaps no other area is under more scrutiny than financial remuneration to doctors. Even the appearance of a conflict of interest can cause issues. The pharmaceutical and biotechnology industries must hire Key Opinion Leaders, KOLs, for many services—including professional education, clinical research, advisory boards, medical policy and guideline boards, and strategic communications. Balancing the need to hire KOLs with the compliance risks requires care throughout the entire process. Bias, and thus possible conflicts, can even be found in the KOL identification and selection process.
Who Should Read This: Medical and Biomedical executives involved in developing thought leadership, plus advocates in scientific advisory board and medical affairs KOL capacities.
Specifically:
- KOL Relationship Management
- Opinion Leader Relations
- Medical and Scientific Affairs
- Scientific Advisory Board Managers
- Senior Marketing Managers
- Medical Science Liaisons
- Medical Research Executives
- Advocacy Development
- Market Research
- Brand and Product Management
Why This is Important: Pharmaceutical and biotechnology companies are affected by ongoing changes in legislation surrounding the appropriate use of industry thought leadership in development and marketing of medical products. Companies that evolve their advocacy strategies using undiscovered relationships and powerful people often find their go-to-market strategies positively impacted.
Free Download. Please provide your name and email to be added to future notices about our research. We respect your privacy.
Required fields are marked [*].